Press release
Vitiligo Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Incyte, Amgen, Boston Pharma, Arcutis, Pfizer, Dermavant Sciences, Clinuvel, Celgene, AXIM Biotechnologies, Arrien
"Vitiligo Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Vitiligo Therapeutics Market.
The report provides a detailed description of the Vitiligo drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.
Get a Detailed Overview of the Vitiligo Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/vitiligo-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Vitiligo Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Vitiligo therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Vitiligo treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Vitiligo drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Vitiligo treatment market.
Learn More about the Clinical and Commercial Development Activities in the Vitiligo Therapeutics Domain:
https://www.delveinsight.com/report-store/vitiligo-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Vitiligo Therapeutics Analysis
There is no cure for vitiligo. Most treatments are prescribed "off-label". The goal of medical treatment is to create a uniform skin tone by either restoring color (repigmentation) or eliminating the remaining color (depigmentation). It is more common in people with autoimmune diseases, and it might run in families. It usually starts before age 40. Oral and topical prescription medications, light therapy, surgical procedures, and some lifestyle changes can help people manage vitiligo. Monobenzone: Monobenzone was the only FDA-approved treatment for vitiligo, although it is no longer marketed.
There are 22+ key major pharma and biotech giants actively developing therapies for Vitiligo. Currently, Incyte Corporation is leading the therapeutics market with its Vitiligo drug candidates in the most advanced stage of clinical development.
• On March 18, 2023, Incyte (Nasdaq: INCY) announced new data from a Phase 2b clinical trial evaluating the safety and efficacy of povorcitinib (INCB54707), an investigational oral JAK1 inhibitor, in adult patients with extensive nonsegmental vitiligo. These data were presented today in a late-breaking oral presentation (Session: S042 - Late-Breaking Research: Session 2) at the 2023 American Academy of Dermatology (AAD) Annual Meeting, held from March 17-21 in New Orleans.
• On January 09, 2023, VYNE Therapeutics Inc. (Nasdaq: VYNE) ("VYNE" or the "Company") announced that the first vitiligo patient has been dosed in a Phase 1a/b clinical trial of VYN201. VYN201 is a locally administered, small molecule, pan-bromodomain and extra-terminal domain (BET) inhibitor that is being developed for the treatment of immuno-inflammatory diseases. The clinical trial is a first-in-human study designed to generate safety and pharmacokinetic data in healthy volunteers (Phase 1a) as well as provide early clinical proof-of-concept data in vitiligo patients (Phase 1b).
• In July 2022, the US FDA approved topical OPZELURA (ruxolitinib) 1.5% in patients 12 years of age or older for the treatment of non-segmental vitiligo. It is a white to off-white oil-in-water, solubilized emulsion cream with a maximum dosage of 60 g per week. It is soon expected to be approved in the EU.
Vitiligo Companies in the Therapeutics Market Include:
• Incyte Corporation
• Amgen
• Boston Pharmaceuticals
• Arcutis Biotherapeutics
• Pfizer
• Dermavant Sciences
• Clinuvel Pharmaceuticals
• Celgene
• TWi Biotechnology
• AXIM Biotechnologies
• Arrien Pharmaceuticals
And Many Others
Emerging and Marketed Vitiligo Therapies Covered in the Report Include:
• Ruxolitinib: Incyte Corporation
• AMG-714: Amgen
• ATI-1777: Aclaris Therapeutics
• TT-01: Temprian Therapeutics
• 1BNZ-1: Bioniz Therapeutics
• Phimelanotide Clinuvel Pharmaceuticals
• AC-1101: TWi Biotechnology
• PF-06651600: Pfizer
• Cerdulatinib: Dermavant Sciences
• SHR0302 ointment: Reistone Biopharma Company Limited
And many more
Get an in-depth Assessment of the Emerging Therapies and Vitiligo Companies Actively Working in the Market @
https://www.delveinsight.com/sample-request/vitiligo-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
The Report Covers the Emerging Vitiligo Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued and inactive candidates
Route of Administration
Vitiligo pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Oral
• Parenteral
• Intravitreal
• Subretinal
• Topical.
Molecule Type
Products have been categorized under various Molecule types such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy
Request for Sample PDF to Understand More About the Vitiligo Treatment Outlook and Future Perspectives @
https://www.delveinsight.com/sample-request/vitiligo-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Vitiligo Current Treatment Patterns
4. Vitiligo - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Vitiligo Late-Stage Products (Phase-III)
7. Vitiligo Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Vitiligo Discontinued Products
13. Vitiligo Product Profiles
14. Vitiligo Companies
15. Vitiligo Drugs
16. Dormant and Discontinued Products
17. Vitiligo Unmet Needs
18. Vitiligo Future Perspectives
19. Vitiligo Analyst Review
20. Appendix
21. Report Methodology
Get Detailed Insights About the Reports Offerings @
https://www.delveinsight.com/sample-request/vitiligo-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
------------------------------------------------------------------------------------------------------------------------------
Discover DelveInsight's Comprehensive Market Research and Consulting Services:
https://www.delveinsight.com/market-research
Elevate your industry insights with our comprehensive medical devices market assessment reports. Visit to gain a strategic edge through expert analysis and in-depth coverage of the latest trends, innovations, and market dynamics, at:
https://www.delveinsight.com/medical-devices
Empowering Cancer Care: DelveInsight's oncology consulting services offer personalized guidance and cutting-edge expertise to navigate the ongoing clinical, commercial, and regulatory developments, visit for more details:
https://www.delveinsight.com/oncology
Other Trending Healthcare Reports by DelveInsight
Metrorrhagia Market
https://www.delveinsight.com/report-store/metrorrhagia-market
Dysfunctional Uterine Bleeding Market
https://www.delveinsight.com/report-store/dysfunctional-uterine-bleeding-market
Status Epilepticus Market
https://www.delveinsight.com/report-store/status-epilepticus-market
Brain Hemorrhage Market
https://www.delveinsight.com/report-store/brain-hemorrhage-market
Congenital Adrenal Hyperplasia Market
https://www.delveinsight.com/report-store/congenital-adrenal-hyperplasia-market
Ductal Carcinoma in Situ Market
https://www.delveinsight.com/report-store/ductal-carcinoma-in-situ-market
Electroencephelographs (EEG) Pipeline Insight
https://www.delveinsight.com/report-store/electroencephelographs-eeg-pipeline-insight-and-competitive-landscape
Spinal Decompression/Traction Devices Market
https://www.delveinsight.com/report-store/spinal-decompression-traction-devices-market
Bronchopulmonary Dysplasia Market
https://www.delveinsight.com/report-store/bronchopulmonary-dysplasia-market
Drug Hypersensitivity Market
https://www.delveinsight.com/report-store/drug-hypersensitivity-market
Familial Chylomicronemia Syndrome (FCS) Market
https://www.delveinsight.com/report-store/familial-chylomicronemia-syndrome-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Postmyocardial Infarction Syndrome Market
https://www.delveinsight.com/report-store/postmyocardial-infarction-syndrome-market
Surgery and Radiation Therapy in Brain Cancer Market
https://www.delveinsight.com/report-store/surgery-and-radiation-therapy-in-brain-cancer-market
Acute ischemic stroke (AIS) Market
https://www.delveinsight.com/report-store/acute-ischemic-stroke-ais-market
Acute On Chronic Liver Failure (ACLF) Market
https://www.delveinsight.com/report-store/acute-on-chronic-liver-failure-aclf-market
Biliary Tract Cancers (BTCs) Market
https://www.delveinsight.com/report-store/biliary-tract-cancers-btcs-market
Gene Therapy for Ocular Rare Disease Market
https://www.delveinsight.com/report-store/gene-therapy-for-ocular-rare-disease-market
Hemophagocytic Lymphohistiocytosis Market
https://www.delveinsight.com/report-store/hemophagocytic-lymphohistiocytosis-market
Staphylococcus Aureus Infection Market
https://www.delveinsight.com/report-store/staphylococcus-aureus-infection-market
Treatment-Resistant Hypertension Market
https://www.delveinsight.com/report-store/treatment-resistant-hypertension-market
Urticaria Or Hives Market
https://www.delveinsight.com/report-store/urticaria-or-hives-market
Acute Heart failure Market
https://www.delveinsight.com/report-store/acute-heart-failure-ahf-market
Bowen's Disease Market
https://www.delveinsight.com/report-store/bowens-disease-market
Contrast-Induced Nephropathy Market
https://www.delveinsight.com/report-store/contrast-induced-nephropathy-market
Delirium Market
https://www.delveinsight.com/report-store/delirium-market
Dry AMD MarketEGFR Inhibitors-Induced Skin Disorders Market
https://www.delveinsight.com/report-store/egfr-inhibitors-induced-skin-disorders-market
Excessive Daytime Sleepiness (EDS) Market
https://www.delveinsight.com/report-store/excessive-daytime-sleepiness-eds-market
Gene and Cell Therapies Targeting CNS Disorders Market
https://www.delveinsight.com/report-store/gene-and-cell-therapies-targeting-cns-disorders-market
Glioma Market
https://www.delveinsight.com/report-store/glioma-market
Graves Ophthalmopathy Market
https://www.delveinsight.com/report-store/graves-ophthalmopathy-market
H3N2 Infection Market
https://www.delveinsight.com/report-store/h3n2-infection-market
Nontuberculous Mycobacterial (NTM) Infections Market
https://www.delveinsight.com/report-store/nontuberculous-mycobacterial-ntm-infections-market
Pars Plantis Market
https://www.delveinsight.com/report-store/pars-plantis-market
Pneumothorax Treatment Devices Market
https://www.delveinsight.com/report-store/pneumothorax-treatment-devices-market
Portal Hypertension Market
https://www.delveinsight.com/report-store/portal-hypertension-market
Decompensated Cirrhosis Market
https://www.delveinsight.com/report-store/decompensated-cirrhosis-market
Follicular Lymphoma Market
https://www.delveinsight.com/report-store/follicular-lymphoma-market-insights
Osteochondromas Market
https://www.delveinsight.com/report-store/osteochondromas-market
Hidradenitis Suppurativa Market
https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
IgG4-Related Disease Market
https://www.delveinsight.com/report-store/igg4-related-disease-market
Lichen Planus Market
https://www.delveinsight.com/report-store/lichen-planus-market
Retinal Vein Occlusion Market
https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
Meniere's Disease Market
https://www.delveinsight.com/report-store/menieres-disease-md-market
Cytokine Release Syndrome Market
https://www.delveinsight.com/report-store/cytokine-release-syndrome-market
Angelman Syndrome Market
https://www.delveinsight.com/report-store/angelman-syndrome-market-forecast
Eosinophilic Gastroenteritis (EGE) Market
https://www.delveinsight.com/report-store/eosinophilic-gastroenteritis-ege-market
Hereditary Transthyretin Amyloidosis (hATTR) Market
https://www.delveinsight.com/report-store/hereditary-transthyretin-amyloidosis-competitive-landscape-and-market
Implantable Infusion Pumps Market
https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
Post-Operative Cataract Surgery Inflammation Market
https://www.delveinsight.com/report-store/post-operative-cataract-surgery-inflammation-market
Antibody-mediated Rejection Market
https://www.delveinsight.com/report-store/antibody-mediated-rejection-market
Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vitiligo Pipeline Analysis (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals, Competitive Landscape | Incyte, Amgen, Boston Pharma, Arcutis, Pfizer, Dermavant Sciences, Clinuvel, Celgene, AXIM Biotechnologies, Arrien here
News-ID: 3246113 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Vitiligo
Organic Care Australia Introduces 'Vitiligo Organics' - A Revolutionary Herbal T …
Image: https://www.getnews.info/uploads/39ec7fd227c4937add1acccc27f32c1b.jpg
Organic Care Australia proudly announced the launch of 'Vitiligo Organics' in 2009, a revolutionary herbal treatment that promises new hope for individuals living with vitiligo, a condition characterized by the loss of skin pigmentation resulting in white patches. This innovative product represents a significant breakthrough in the management of vitiligo, offering a natural, effective solution for those who have long sought an alternative to conventional treatments.
Vitiligo impacts millions worldwide,…
Vitiligo Treatment Market - Unleash Your True Colors: Breakthrough Vitiligo Trea …
Newark, New Castle, USA: The "Vitiligo Treatment Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Vitiligo Treatment Market: https://www.growthplusreports.com/report/vitiligo-treatment-market/7780
This latest report researches the industry structure, sales, revenue,…
Vitiligo - Drug Pipeline Landscape, 2022
Vitiligo is a chronic disorder that causes patches of skin to lose pigment or color, when melanocytes are attacked and destroyed, causing the skin to turn a milky-white color. There are two types of vitiligo such as nonsegmental or generalized vitiligo and segmental vitiligo. Nonsegmental or generalized vitiligo happens when the white patches appear symmetrically on both sides of body, such as on both hands or both knees. Segmental vitiligo…
Vitiligo Treatment Market: Rising Impressive Business Opportunities Analysis For …
Vitiligo Treatment Market Report 2022: Industry aims to provide an overview of the industry through detailed market segmentation. The report offers thorough information about the overview and scope of the market along with its drivers, restraints, and trends. This report is designed to include both qualitative and quantitative aspects of the industry in each region and country participating in the study.
Get a Sample PDF of the Report @ https://impeccablemarketresearch.com/enquiry/request-sample-pdf/14636671?utm_source=Openpr&utm_medium=Shubhamko
…
Vitiligo Skin Disorder
Vitiligo Skin Disorder
Vitiligo skin disorder is a skin condition in which white patches on the skin are formed due to malfunctioning of melanocytes, cells that promote pigmentation. http://www.curevitiligooil.com/Vitiligo-Skin-Disorder.htmlThe start of this disease and the grimness of pigment loss vary from person to person. People who have light skin usually witness the loss of pigment in summers because the contrast between depigmented skin and sunburned skin appears distinctive. On the other…
Vitiligo Symptoms
Vitiligo produces macules which are small areas of different skin color. The skin disorder may also produce patches which are flat, pale or white and can't be felt with fingers. (http://www.curevitiligooil.com/Vitiligo-Symptoms.html). These marks frequently expand to form very large, irregularly-shaped areas with no pigmentation. Typically, these are painless and do not itch. The cause of vitiligo symptoms is not known, but autoimmunity may be a factor. Since it is a…
